Global Diphtheria Vaccines Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Diphtheria Vaccines Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Diphtheria is a bacterial infection caused by Corynebacterium diphtheriae, and it spreads through respiratory droplets and close physical contact. Diphtheria Vaccine is a vaccine produced from diphtheria toxoid (a non-toxic form of the toxin) that against Corynebacterium diphtheriae.
Diphtheria Vaccines report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Diphtheria Vaccines market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Adults and Children are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Diphtheria Vaccines industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Diphtheria Vaccines key manufacturers include Sanofi Pasteur, GlaxoSmithKline, Bharat Biotech and Merck, etc. Sanofi Pasteur, GlaxoSmithKline, Bharat Biotech are top 3 players and held % sales share in total in 2022.
Diphtheria Vaccines can be divided into DTaP Vaccines, Tdap Vaccines, Td Vaccines and DT Vaccines, etc. DTaP Vaccines is the mainstream product in the market, accounting for % sales share globally in 2022.
Diphtheria Vaccines is widely used in various fields, such as Adults and Children, etc. Adults provides greatest supports to the Diphtheria Vaccines industry development. In 2022, global % sales of Diphtheria Vaccines went into Adults filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Diphtheria Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Sanofi Pasteur
GlaxoSmithKline
Bharat Biotech
Merck
Segment by Type
DTaP Vaccines
Tdap Vaccines
Td Vaccines
DT Vaccines
Adults
Children
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Diphtheria Vaccines market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Diphtheria Vaccines, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Diphtheria Vaccines industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Diphtheria Vaccines in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Diphtheria Vaccines introduction, etc. Diphtheria Vaccines Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Diphtheria Vaccines market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Diphtheria Vaccines report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Diphtheria Vaccines market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Adults and Children are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Diphtheria Vaccines industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Diphtheria Vaccines key manufacturers include Sanofi Pasteur, GlaxoSmithKline, Bharat Biotech and Merck, etc. Sanofi Pasteur, GlaxoSmithKline, Bharat Biotech are top 3 players and held % sales share in total in 2022.
Diphtheria Vaccines can be divided into DTaP Vaccines, Tdap Vaccines, Td Vaccines and DT Vaccines, etc. DTaP Vaccines is the mainstream product in the market, accounting for % sales share globally in 2022.
Diphtheria Vaccines is widely used in various fields, such as Adults and Children, etc. Adults provides greatest supports to the Diphtheria Vaccines industry development. In 2022, global % sales of Diphtheria Vaccines went into Adults filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Diphtheria Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Sanofi Pasteur
GlaxoSmithKline
Bharat Biotech
Merck
Segment by Type
DTaP Vaccines
Tdap Vaccines
Td Vaccines
DT Vaccines
Segment by Application
Adults
Children
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Diphtheria Vaccines market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Diphtheria Vaccines, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Diphtheria Vaccines industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Diphtheria Vaccines in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Diphtheria Vaccines introduction, etc. Diphtheria Vaccines Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Diphtheria Vaccines market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.